注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Seer Inc是一家生命科學公司。該公司致力於開髮變革性產品。該公司的初始產品Proteograph產品套件利用工程納米顆粒(NP)技術提供對蛋白質組的大規模訪問。Proteograph產品套件是一項集成解決方案,由耗材、自動化儀器和軟件組成。它的方法基於工程化的NP,能夠在蛋白質組的動態範圍內對完整蛋白質進行無偏採樣,在蛋白質變體以及蛋白質-蛋白質相互作用(PPI)水平上捕獲大量分子信息。它專注於與蛋白質組學和基因組學市場的客戶一起採用Proteograph。該公司最初專注於Proteograph產品套件的研究應用,並且正在銷售和推廣Proteograph僅供研究使用 (RUO),從而消除對其他公正方法所需複雜工作流程的需求。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
David B. Singer | 58 | 2017 | Independent Director |
David L. Hallal | 56 | 2018 | Lead Independent Director |
Mark B. McClellan | 59 | - | Member of Scientific Advisory Board |
Vivek Farias | - | - | Member of Scientific Advisory Board |
Steven A. Carr | - | - | Member of Scientific Advisory Board |
Charles R. Cantor | 80 | - | Member of Scientific Advisory Board |
Luis Alberto Diaz | 52 | - | Member of Scientific & Clinical Advisory Board |
Omid C. Farokhzad | 54 | 2017 | Founder, CEO, & Chair of the Board of Directors |
Robert S. Langer | 74 | 2017 | Co-Chairman of Scientific Advisory Board & Director |
Rachel E. Haurwitz | 37 | 2021 | Independent Director |
Joshua Coon | - | 2023 | Member of Scientific & Clinical Advisory Board |
Bruce Wilcox | - | 2023 | Member of Scientific Advisory Board |
Meeta Gulyani | 55 | 2021 | Independent Director |
Terrance G. McGuire | 68 | 2017 | Independent Director |
Dipchand V. Nishar | 55 | 2021 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核